Cargando…

Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application

Development of specific and selective boron carriers is indispensable for boron neutron capture therapy (BNCT) application. Pentagamaboronon-0 (PGB-0) is a promising candidate as boron carrier compound due to the low but selective cytotoxicity in breast cancer cells. Formerly we reported synthesis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Susidarti, Ratna Asmah, Utomo, Rohmad Yudi, Qodria, Lailatul, Ramadani, Ratna Dwi, Ohta, Youichiro, Hattori, Yoshihide, Kirihata, Mitsunori, Meiyanto, Edy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714113/
https://www.ncbi.nlm.nih.gov/pubmed/31516505
http://dx.doi.org/10.4103/1735-5362.263552
_version_ 1783446992256499712
author Susidarti, Ratna Asmah
Utomo, Rohmad Yudi
Qodria, Lailatul
Ramadani, Ratna Dwi
Ohta, Youichiro
Hattori, Yoshihide
Kirihata, Mitsunori
Meiyanto, Edy
author_facet Susidarti, Ratna Asmah
Utomo, Rohmad Yudi
Qodria, Lailatul
Ramadani, Ratna Dwi
Ohta, Youichiro
Hattori, Yoshihide
Kirihata, Mitsunori
Meiyanto, Edy
author_sort Susidarti, Ratna Asmah
collection PubMed
description Development of specific and selective boron carriers is indispensable for boron neutron capture therapy (BNCT) application. Pentagamaboronon-0 (PGB-0) is a promising candidate as boron carrier compound due to the low but selective cytotoxicity in breast cancer cells. Formerly we reported synthesis of PGB-0 which was ineffective due to its low aqueous solubility. In the present study, we, therefore, introduced the new PGB-0 preparation complexed with sugars to increase its solubility in water. By synthesizing at room temperature and using flash chromatography for the purification, we produced PGB-0 with a yield of 40%. PGB-0 fructose complex (PGB-0-F) and PGB-0 sorbitol complex (PGB-0-Sor) were obtained with smaller particle size compared to PGB-0 suspension in water. Based on the MTT assay, the cytotoxicity of PGB-0-F and PGB-0-Sor were higher than PGB-0 even though still categorized as low cytotoxic agents. In conclusion, we provided PGB-0 with a new method and improved its solubility in water. Further investigations are still needed to develop more efficient PGB-0 as boron carrier for BNCT in various cancers.
format Online
Article
Text
id pubmed-6714113
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-67141132019-09-12 Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application Susidarti, Ratna Asmah Utomo, Rohmad Yudi Qodria, Lailatul Ramadani, Ratna Dwi Ohta, Youichiro Hattori, Yoshihide Kirihata, Mitsunori Meiyanto, Edy Res Pharm Sci Original Article Development of specific and selective boron carriers is indispensable for boron neutron capture therapy (BNCT) application. Pentagamaboronon-0 (PGB-0) is a promising candidate as boron carrier compound due to the low but selective cytotoxicity in breast cancer cells. Formerly we reported synthesis of PGB-0 which was ineffective due to its low aqueous solubility. In the present study, we, therefore, introduced the new PGB-0 preparation complexed with sugars to increase its solubility in water. By synthesizing at room temperature and using flash chromatography for the purification, we produced PGB-0 with a yield of 40%. PGB-0 fructose complex (PGB-0-F) and PGB-0 sorbitol complex (PGB-0-Sor) were obtained with smaller particle size compared to PGB-0 suspension in water. Based on the MTT assay, the cytotoxicity of PGB-0-F and PGB-0-Sor were higher than PGB-0 even though still categorized as low cytotoxic agents. In conclusion, we provided PGB-0 with a new method and improved its solubility in water. Further investigations are still needed to develop more efficient PGB-0 as boron carrier for BNCT in various cancers. Wolters Kluwer - Medknow 2019-08 /pmc/articles/PMC6714113/ /pubmed/31516505 http://dx.doi.org/10.4103/1735-5362.263552 Text en Copyright: © 2019 Research in Pharmaceutical Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Susidarti, Ratna Asmah
Utomo, Rohmad Yudi
Qodria, Lailatul
Ramadani, Ratna Dwi
Ohta, Youichiro
Hattori, Yoshihide
Kirihata, Mitsunori
Meiyanto, Edy
Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
title Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
title_full Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
title_fullStr Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
title_full_unstemmed Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
title_short Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
title_sort preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (bnct) application
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714113/
https://www.ncbi.nlm.nih.gov/pubmed/31516505
http://dx.doi.org/10.4103/1735-5362.263552
work_keys_str_mv AT susidartiratnaasmah preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication
AT utomorohmadyudi preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication
AT qodrialailatul preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication
AT ramadaniratnadwi preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication
AT ohtayouichiro preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication
AT hattoriyoshihide preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication
AT kirihatamitsunori preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication
AT meiyantoedy preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication